PROTARA THERAPEUTICS
Protara Therapeutics develops transformative therapies for people with cancer and rare diseases. Protara’s portfolio includes its lead program, TARA-002, an investigational cell-based therapy created for the treatment of non-muscle invasive bladder cancer and lymphatic malformations, and IV Choline Chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure-associated liver disease. The Protara team prioritizes creativity, diverse perspectives, and tenacity to expedite their goal of bringing life-changing therapies to people with limited treatment options.
PROTARA THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2017-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.protaratx.com
Total Employee:
11+
Status:
Active
Contact:
646-844-0337
Email Addresses:
[email protected]
Total Funding:
4.15 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail IPv6 Microsoft Azure DNS GoDaddy DNS Digital Ocean Akamai Hosted IHS Markit
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Advisors List
Current Employees Featured
Founder
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-21 | Protara Therapeutics Announces Departure of Chief Financial Officer |
| 2022-01-10 | Protara Therapeutics Announces Appointment of Jathin Bandari, M.D. as Chief Medical Officer |
Official Site Inspections
http://www.protaratx.com
- Host name: protara.wpmudev.host
- IP address: 104.156.225.247
- Location: Matawan United States
- Latitude: 40.4652
- Longitude: -74.2307
- Metro Code: 501
- Timezone: America/New_York
- Postal: 07747
More informations about "Protara Therapeutics"
ABOUT US | Protara Therapeutics
ABOUT US Main Menu OUR STORY LEADERSHIP BOARD OF DIRECTORS Main Menu OUR STORY LEADERSHIP BOARD OF DIRECTORS Protara is committed to advancing …See details»
Protara Therapeutics - LinkedIn
Protara Therapeutics | 4,229 followers on LinkedIn. Tenacious in our search for transformative therapies | Protara is committed to advancing transformative therapies for people with cancer …See details»
Protara Therapeutics - Crunchbase Company Profile & Funding
Protara Therapeutics develops transformative therapies for people with cancer and rare diseases with limited treatment options.See details»
Protara Therapeutics, Inc. - Executive Bio, Top Executies, and ...
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.See details»
Protara Therapeutics Overview | SignalHire Company Profile
The Protara Therapeutics annual revenue is estimated at < 1M. To connect with Protara Therapeutics employee register on SignalHire. Organization Website protaratx.com Social …See details»
Protara Therapeutics
Protara Therapeutics, Inc. 345 Park Avenue South 3rd Floor New York, NY 10010 Phone: +1 646-844-0337 [email protected] About Us Pipeline Careers Investors Contact UsSee details»
Protara Therapeutics CEO and key executive team - Craft.co
Protara Therapeutics's Co-founder, Director, Chief Executive Officer is Jesse Shefferman. Other executives include Luke Beshar, Chairman; Michael Solomon, Director and 8 others. See the …See details»
Protara Therapeutics - workinbiotech.com
Protara Therapeutics is identifying therapies for the treatment of cancer and rare diseases. Protara’s lead candidate, TARA-002, is approved in Japan and Taiwan for multiple oncogenic …See details»
Protara Therapeutics Appoints William Conkling as Chief ... - Nasdaq
Jun 2, 2025 Protara Therapeutics appoints Bill Conkling as Chief Commercial Officer, enhancing its leadership in cancer and rare disease therapeutics.See details»
LEADERSHIP | Protara Therapeutics
Jesse Shefferman is a co-founder of Protara and has led the Company since its inception through the addition of two late-stage assets, the establishment of multiple late-stage development programs and its listing on NASDAQ in early …See details»
Investor Overview – Protara Therapeutics, Inc.
May 27, 2025 The Investor Relations website contains information about Protara Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Protara Therapeutics Appoints William Conkling as Chief …
Jun 2, 2025 Potential Positives Appointment of William "Bill" Conkling as Chief Commercial Officer enhances Protara's leadership with over two decades of experience in commercializing …See details»
Corporate Governance – Protara Therapeutics, Inc.
The Board of Directors of Protara Therapeutics (the "Company") sets high standards for the Company's employees, officers and directors. Implicit in this philosophy is the importance of …See details»
Protara Therapeutics Announces Second Quarter 2025 Financial …
Aug 11, 2025 The Investor Relations website contains information about Protara Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
INVESTORS | Protara Therapeutics
Nov 4, 2021 INVESTORS Investor Overview Press releases Events and presentations Analyst coverage Sec filings Stock information Corporate governance Information Request ...See details»
EVENTS AND PRESENTATIONS – Protara Therapeutics, Inc.
The Investor Relations website contains information about Protara Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
BOARD OF DIRECTORS | Protara Therapeutics
Luke Beshar is a seasoned biotechnology executive and financial expert with more than 35 years of general and financial management experience at various public and private companies. Mr. …See details»
Stock Information – Protara Therapeutics, Inc.
The Investor Relations website contains information about Protara Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Protara Announces Proposed Public Offering - ir.protaratx.com
Dec 9, 2024 The Investor Relations website contains information about Protara Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Protara Therapeutics Announces Fourth Quarter and Full Year …
Mar 11, 2021 The Investor Relations website contains information about Protara Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.See details»